Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
Open Access
- 31 July 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 85 (3) , 313-316
- https://doi.org/10.1054/bjoc.2001.1933
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.1999
- The Prognostic Significance of Peritoneal Seeding and Size of Postsurgical Residual in Patients with Stage III Epithelial Ovarian Cancer Treated with Surgery, Chemotherapy, and High-Dose RadiotherapyGynecologic Oncology, 1999
- Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestationPlacenta, 1994
- Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on SurvivalGynecologic Oncology, 1993
- Transcriptional Regulation of Vascular Endothelial Growth Factor Gene Expression in Ovarian Bovine Granulosa CellsGrowth Factors, 1993
- Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.Journal of Clinical Investigation, 1993
- Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGFScience, 1989
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Tumor AngiogenesisPublished by Elsevier ,1985
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983